Booz Allen Hamilton Holding Corporation (BAH) · Other

Bristol-Myers Squibb Co (BMY) · Other

The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of August 17, 2026, for its decision on iberdomide for relapsed or refractory multiple myeloma, scheduled. Low impact estimated as the target date is a procedural milestone.

8/17/2026, 12:00:00 AM

MSC Industrial Direct Co Inc. (MSM) · Earnings Release

Fiscal Q3 2026 earnings release is scheduled; Low importance estimated as it is a routine financial disclosure.

7/7/2026, 12:00:00 AM

NIKE Inc (NKE) · Earnings Release

Q4 Fiscal Year 2026 earnings release is scheduled for June 25, 2026. Low importance as the announcement of the date typically has a minimal market impact.

6/25/2026, 12:00:00 AM

Williams Cos Inc. (The) (WMB) · Other

On April 28, 2026, the board approved a 5% quarterly dividend increase to $0.525 per share. The ex-dividend date is June 12, 2026.

6/12/2026, 12:00:00 AM

DICK'S Sporting Goods Inc (DKS) · Earnings Release

Q1 2026 earnings release is scheduled for 2026-05-27. Medium importance estimated as earnings releases for high-growth companies typically result in ≥5% price movement. Analysts forecast EPS of approximately $2.93 forecasted.

5/27/2026, 12:00:00 AM

Booz Allen Hamilton Holding Corporation (BAH) · Earnings Release

Booz Allen Hamilton is scheduled to release its Fourth Quarter and Full Year Fiscal 2026 financial results before the market opens on May 22, 2026; high importance is estimated as annual results can lead to price swings exceeding 10%, scheduled.

5/22/2026, 12:00:00 AM